In MS patients, lower cerebral SvO2 (compared with HCs) is statistically associated with microstructural alterations in the NAWM. Our mediation models are consistent with a pathway whereby lower SvO2 is associated with greater lesion burden and worse functional scores via its association with NAWM damage. These findings support the exploratory value of SvO2 and NAWM integrity as potential biomarkers for monitoring MS progression, which warrants validation in further longitudinal studies.
Wang et al. (Fri,) studied this question.